Accelerating antiviral drug discovery: lessons from COVID-19
During the coronavirus disease 2019 (COVID-19) pandemic, a wave of rapid and collaborative drug discovery efforts took place in academia and industry, culminating in several therapeutics being discovered, approved and deployed in a 2-year time frame. This article summarizes the collective experience...
Asıl Yazarlar: | von Delft, A, Hall, MD, Kwong, AD, Purcell, LA, Saikatendu, KS, Schmitz, U, Tallarico, JA, Lee, AA |
---|---|
Materyal Türü: | Journal article |
Dil: | English |
Baskı/Yayın Bilgisi: |
Springer Nature
2023
|
Benzer Materyaller
-
Antiviral research : strategies in antiviral drug discovery /
Yazar:: LaFemina, Robert L., ve diğerleri
Baskı/Yayın Bilgisi: (c200) -
Successful strategies for the discovery of antiviral drugs /
Yazar:: Desai, Manoj C., ve diğerleri
Baskı/Yayın Bilgisi: (2013) -
Recommender Systems in Antiviral Drug Discovery
Yazar:: Ekaterina A. Sosnina, ve diğerleri
Baskı/Yayın Bilgisi: (2020-06-01) -
Glycobiology against viruses: Antiviral drug discovery
Yazar:: Zitzmann, N, ve diğerleri
Baskı/Yayın Bilgisi: (2006) -
A phenomics approach for antiviral drug discovery
Yazar:: Jonne Rietdijk, ve diğerleri
Baskı/Yayın Bilgisi: (2021-08-01)